Vermox Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Form (Oral Suspension, Chewable Tablets); Distribution Channel (Hospital and Retail Pharmacies, Online Distribution), and Geography

Report Code: TIPRE00022339 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Vermox is a prescription medicine used to treat infection symptoms caused by hookworm, roundworm, whipworm, and pinworm. The medicine is orally administered can be used for children and adults. The dosage of the tablet varies based on the infection caused by the above-listed worms.

MARKET SCOPE

The "Global Vermox Market Analysis to 2028" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the vermox market with detailed market segmentation by form, distribution channel and geography. The report provides key statistics on the market status of the leading vermox market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
  •   Based on form, the global vermox market is segmented into oral suspension, and chewable tablets.
  •   Based on distribution channel, the market is bifurcated into hospital and retail pharmacies, and oline distribution.
MARKET DYNAMICS

Drivers-
  •   Increasing symptomps of worm among children below two years
  •   Growing production and FDA approvals for perdiatic medicines
  •   Rising symptoms of intestinal worms among adults
  •   Gorwing production of pharmaceutical products
Restraints-
  •   The stringent regulatory reforms may hinder the growth of market during the forecast period.
REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The vermox market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the vermox market in these regions.

IMPACT OF COVID-19 ON VERMOX MARKET

COVID-19 pandemic has affected the pharmaceutical industry to a great extent. The limited offline distribution channels have hindered the growth of various pharmaceutical segments, including Vermox. The widely affected regions by the poor distribution channels were the Middle East and Africa and South and Central America. However, the market has gained a good market value due to an increase in online distribution in the local areas and within the country.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the vermox market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from vermox market are anticipated to lucrative growth opportunities in the future with the rising demand for vermox in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the vermox market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •   Esteve Pharmaceuticals
  •   Amneal Pharmaceuticals, Inc.
  •   Johnson and Johnson
  •   Cadila Pharmaceuticals
  •   Tenry Pharmaceutical
  •   Eipico
  •   Physicians Total Care, Inc.
  •   Amedra Pharmaceuticals LLC
  •   Teva Pharmaceutical Industries Ltd.
  •   Bryant Ranch Prepack, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vermox Market - By Form
1.3.2 Vermox Market - By Distribution Channel
1.3.3 Vermox Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VERMOX MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VERMOX MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VERMOX MARKET - GLOBAL MARKET ANALYSIS
6.1. VERMOX - GLOBAL MARKET OVERVIEW
6.2. VERMOX - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. VERMOX MARKET - REVENUE AND FORECASTS TO 2028 - FORM
7.1. OVERVIEW
7.2. FORM MARKET FORECASTS AND ANALYSIS
7.3. ORAL SUSPENSION
7.3.1. Overview
7.3.2. Oral Suspension Market Forecast and Analysis
7.4. CHEWABLE TABLETS
7.4.1. Overview
7.4.2. Chewable Tablets Market Forecast and Analysis
8. VERMOX MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL AND RETAIL PHARMACIES
8.3.1. Overview
8.3.2. Hospital and Retail Pharmacies Market Forecast and Analysis
8.4. ONLINE DISTRIBUTION
8.4.1. Overview
8.4.2. Online Distribution Market Forecast and Analysis
9. VERMOX MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Vermox Market Overview
9.1.2 North America Vermox Market Forecasts and Analysis
9.1.3 North America Vermox Market Forecasts and Analysis - By Form
9.1.4 North America Vermox Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Vermox Market Forecasts and Analysis - By Countries
9.1.5.1 United States Vermox Market
9.1.5.1.1 United States Vermox Market by Form
9.1.5.1.2 United States Vermox Market by Distribution Channel
9.1.5.2 Canada Vermox Market
9.1.5.2.1 Canada Vermox Market by Form
9.1.5.2.2 Canada Vermox Market by Distribution Channel
9.1.5.3 Mexico Vermox Market
9.1.5.3.1 Mexico Vermox Market by Form
9.1.5.3.2 Mexico Vermox Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Vermox Market Overview
9.2.2 Europe Vermox Market Forecasts and Analysis
9.2.3 Europe Vermox Market Forecasts and Analysis - By Form
9.2.4 Europe Vermox Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Vermox Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Vermox Market
9.2.5.1.1 Germany Vermox Market by Form
9.2.5.1.2 Germany Vermox Market by Distribution Channel
9.2.5.2 France Vermox Market
9.2.5.2.1 France Vermox Market by Form
9.2.5.2.2 France Vermox Market by Distribution Channel
9.2.5.3 Italy Vermox Market
9.2.5.3.1 Italy Vermox Market by Form
9.2.5.3.2 Italy Vermox Market by Distribution Channel
9.2.5.4 Spain Vermox Market
9.2.5.4.1 Spain Vermox Market by Form
9.2.5.4.2 Spain Vermox Market by Distribution Channel
9.2.5.5 United Kingdom Vermox Market
9.2.5.5.1 United Kingdom Vermox Market by Form
9.2.5.5.2 United Kingdom Vermox Market by Distribution Channel
9.2.5.6 Rest of Europe Vermox Market
9.2.5.6.1 Rest of Europe Vermox Market by Form
9.2.5.6.2 Rest of Europe Vermox Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Vermox Market Overview
9.3.2 Asia-Pacific Vermox Market Forecasts and Analysis
9.3.3 Asia-Pacific Vermox Market Forecasts and Analysis - By Form
9.3.4 Asia-Pacific Vermox Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Vermox Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Vermox Market
9.3.5.1.1 Australia Vermox Market by Form
9.3.5.1.2 Australia Vermox Market by Distribution Channel
9.3.5.2 China Vermox Market
9.3.5.2.1 China Vermox Market by Form
9.3.5.2.2 China Vermox Market by Distribution Channel
9.3.5.3 India Vermox Market
9.3.5.3.1 India Vermox Market by Form
9.3.5.3.2 India Vermox Market by Distribution Channel
9.3.5.4 Japan Vermox Market
9.3.5.4.1 Japan Vermox Market by Form
9.3.5.4.2 Japan Vermox Market by Distribution Channel
9.3.5.5 South Korea Vermox Market
9.3.5.5.1 South Korea Vermox Market by Form
9.3.5.5.2 South Korea Vermox Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Vermox Market
9.3.5.6.1 Rest of Asia-Pacific Vermox Market by Form
9.3.5.6.2 Rest of Asia-Pacific Vermox Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Vermox Market Overview
9.4.2 Middle East and Africa Vermox Market Forecasts and Analysis
9.4.3 Middle East and Africa Vermox Market Forecasts and Analysis - By Form
9.4.4 Middle East and Africa Vermox Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Vermox Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Vermox Market
9.4.5.1.1 South Africa Vermox Market by Form
9.4.5.1.2 South Africa Vermox Market by Distribution Channel
9.4.5.2 Saudi Arabia Vermox Market
9.4.5.2.1 Saudi Arabia Vermox Market by Form
9.4.5.2.2 Saudi Arabia Vermox Market by Distribution Channel
9.4.5.3 U.A.E Vermox Market
9.4.5.3.1 U.A.E Vermox Market by Form
9.4.5.3.2 U.A.E Vermox Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Vermox Market
9.4.5.4.1 Rest of Middle East and Africa Vermox Market by Form
9.4.5.4.2 Rest of Middle East and Africa Vermox Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Vermox Market Overview
9.5.2 South and Central America Vermox Market Forecasts and Analysis
9.5.3 South and Central America Vermox Market Forecasts and Analysis - By Form
9.5.4 South and Central America Vermox Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Vermox Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Vermox Market
9.5.5.1.1 Brazil Vermox Market by Form
9.5.5.1.2 Brazil Vermox Market by Distribution Channel
9.5.5.2 Argentina Vermox Market
9.5.5.2.1 Argentina Vermox Market by Form
9.5.5.2.2 Argentina Vermox Market by Distribution Channel
9.5.5.3 Rest of South and Central America Vermox Market
9.5.5.3.1 Rest of South and Central America Vermox Market by Form
9.5.5.3.2 Rest of South and Central America Vermox Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VERMOX MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VERMOX MARKET, KEY COMPANY PROFILES
12.1. ESTEVE PHARMACEUTICALS
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMNEAL PHARMACEUTICALS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. JOHNSON AND JOHNSON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CADILA PHARMACEUTICALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. TENRY PHARMACEUTICAL
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. EIPICO
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PHYSICIANS TOTAL CARE, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMEDRA PHARMACEUTICALS LLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRYANT RANCH PREPACK, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS


* Above given report scope is tentative, and may change during the study process as per the research requirement.
* List of companies provided under ‘Company Profile’ chapter is tentative and may change during the course of the study. This list is customizable as per the client requirements.
* Financial information would be provided only for the public companies.
The List of Companies

1. Esteve Pharmaceuticals
2. Amneal Pharmaceuticals, Inc.
3. Johnson and Johnson
4. Cadila Pharmaceuticals
5. Tenry Pharmaceutical
6. Eipico
7. Physicians Total Care, Inc.
8. Amedra Pharmaceuticals LLC
9. Teva Pharmaceutical Industries Ltd.
10. Bryant Ranch Prepack, Inc.
TIPRE00022339
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking